Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Mylan
Biotech
Novartis alums unveil their next act—Chutes & Ladders
Novartis alums Jimenez, Fishman unveil their next act, Deep Genomics nabs a CBO from Synlogics, and Santhera's CMO hits the exit.
Conor Hale
Nov 6, 2020 9:30am
Mylan's Coury steps into exec chairman role—Chutes & Ladders
Apr 17, 2020 9:30am
FDA warns of premature EpiPen auto-injector activations
Mar 25, 2020 11:39am
Viatris appoints Pfizer CFO Narula to C-suite—Chutes & Ladders
Feb 28, 2020 9:30am
Mylan CEO Bresch to exit company after merger—Chutes & Ladders
Aug 2, 2019 9:30am
Teva launches generic EpiPen in the U.S.
Nov 28, 2018 10:15am
